Author: oncologs.com

Innovation Center of NanoMedicine (iCONM; Center Director: Kazunori Kataoka; Location: Kawasaki, Japan) has announced with the Graduate School of Engineering of The University of Tokyo that a group led by Prof. Kanjiro Miyata, Visiting Scientist of iCONM (Professor, Department of Materials Engineering, The University of

Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with  metastatic prostate cancer Credit: Vall d’Hebron Institute of Oncology (VHIO). Novel liquid biopsy methodology enables the monitoring of disease evolution in patients with  metastatic prostate cancer   Extracellular vesicles shed by prostate

Researchers at the Garvan Institute of Medical Research have identified a potential new therapeutic target for pancreatic cancer, one of the most lethal cancer types with limited treatment options. Published in the journal Science Advances, the study shows that blocking the molecule nidogen-2 enhanced the

Research led by the Cancer Biology Laboratory of the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with the Center for Genomic Regulation and the Murcian Institute of Biosanitary Research, has managed to identify the function of the RNF144B gene

The article includes an introduction to the significance of breast cancer, particularly TNBC, and the role of post-translational modifications such as arginine methylation. The study details the expression and functional analysis of CARM1 in breast cancer, its interaction with HIF1A, and its impact on TNBC

Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala University shows that these patients are more vulnerable to other diseases and that the risk of infection for this type of patient should therefore be carefully evaluated. The results of

Most cancer types are identified by studying a sample under the microscope and through immunohistochemistry analysis, which looks for specific proteins in a tumor. For about 3-5% of patients, however — some 60,000 to 100,000 people per year — their cancer’s tissue of origin is

Over the past 35 years, Pennington Biomedical has attracted researchers from around the world to its Baton Rouge campus with the purpose of helping people live longer, healthier lives. These internationally renowned scientists collaborate with their colleagues in 240 academic institutions in 24 countries. Their

Cancer is insidious. Throughout tumor progression, the disease hijacks otherwise healthy biological processes—like the body’s immune response—to grow and spread. When tumors elevate levels of an immune system molecule called Interleukin-6 (IL-6), it can cause severe brain dysfunction. In about 50%-80% of cancer patients, this

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling. Scientists at The University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a human-like gut microbiome that is capable of